Surgical treatment of clinical n1 non-small cell lung cancer

Ongoing controversy over diagnosis and prognosis

Kei Miyoshi, Takeshi Mimura, Koichiro Iwanaga, Shuji Adachi, Noriaki Tsubota, Morihito Okada

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose. The preoperative assessment of nodal status in lung cancer is complicated and problematic for physicians and surgeons. Although many patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) are candidates for surgical treatment, these patients represent a heterogeneous subgroup with unpredictable survival. We conducted this study to evaluate the surgical results of cN1 disease and to attempt to clarify the delicate issues surrounding its diagnosis and prognosis. Methods. The subjects of this study were 187 consecutive patients with cN1 adenocarcinoma or squamous cell carcinoma of the lung, who underwent complete resection without induction therapy. Results. Only 25% of the adenocarcinomas and 54% of the squamous cell carcinomas were correctly diagnosed as N1 disease preoperatively. Multiple logistic regression analyses revealed that adenocarcinoma (P = 0.0141) was a signifi cant predictor of pN2. Multivariate analyses revealed that nodal metastasis (P < 0.0001), large tumor size (P = 0.0079), and high serum carcinoembryonic antigen value (P = 0.0096) were signifi cantly poor prognostic factors in cN1 patients. Conclusions. It is diffi cult to diagnose nodal status in patients with cN1 disease, which requires various surgical procedures, including plasty, possibly with adjuvant therapy in a defi ned high-risk subgroup.

Original languageEnglish
Pages (from-to)428-432
Number of pages5
JournalSurgery today
Volume40
Issue number5
DOIs
Publication statusPublished - May 1 2010

Fingerprint

Non-Small Cell Lung Carcinoma
Adenocarcinoma
Squamous Cell Carcinoma
Therapeutics
Carcinoembryonic Antigen
Lung Neoplasms
Multivariate Analysis
Logistic Models
Regression Analysis
Neoplasm Metastasis
Physicians
Lung
Survival
Serum
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Surgical treatment of clinical n1 non-small cell lung cancer : Ongoing controversy over diagnosis and prognosis. / Miyoshi, Kei; Mimura, Takeshi; Iwanaga, Koichiro; Adachi, Shuji; Tsubota, Noriaki; Okada, Morihito.

In: Surgery today, Vol. 40, No. 5, 01.05.2010, p. 428-432.

Research output: Contribution to journalArticle

Miyoshi, Kei ; Mimura, Takeshi ; Iwanaga, Koichiro ; Adachi, Shuji ; Tsubota, Noriaki ; Okada, Morihito. / Surgical treatment of clinical n1 non-small cell lung cancer : Ongoing controversy over diagnosis and prognosis. In: Surgery today. 2010 ; Vol. 40, No. 5. pp. 428-432.
@article{b5d6354fedc44682bd8b4fbf6709d2e0,
title = "Surgical treatment of clinical n1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis",
abstract = "Purpose. The preoperative assessment of nodal status in lung cancer is complicated and problematic for physicians and surgeons. Although many patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) are candidates for surgical treatment, these patients represent a heterogeneous subgroup with unpredictable survival. We conducted this study to evaluate the surgical results of cN1 disease and to attempt to clarify the delicate issues surrounding its diagnosis and prognosis. Methods. The subjects of this study were 187 consecutive patients with cN1 adenocarcinoma or squamous cell carcinoma of the lung, who underwent complete resection without induction therapy. Results. Only 25{\%} of the adenocarcinomas and 54{\%} of the squamous cell carcinomas were correctly diagnosed as N1 disease preoperatively. Multiple logistic regression analyses revealed that adenocarcinoma (P = 0.0141) was a signifi cant predictor of pN2. Multivariate analyses revealed that nodal metastasis (P < 0.0001), large tumor size (P = 0.0079), and high serum carcinoembryonic antigen value (P = 0.0096) were signifi cantly poor prognostic factors in cN1 patients. Conclusions. It is diffi cult to diagnose nodal status in patients with cN1 disease, which requires various surgical procedures, including plasty, possibly with adjuvant therapy in a defi ned high-risk subgroup.",
author = "Kei Miyoshi and Takeshi Mimura and Koichiro Iwanaga and Shuji Adachi and Noriaki Tsubota and Morihito Okada",
year = "2010",
month = "5",
day = "1",
doi = "10.1007/s00595-008-4072-4",
language = "English",
volume = "40",
pages = "428--432",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Surgical treatment of clinical n1 non-small cell lung cancer

T2 - Ongoing controversy over diagnosis and prognosis

AU - Miyoshi, Kei

AU - Mimura, Takeshi

AU - Iwanaga, Koichiro

AU - Adachi, Shuji

AU - Tsubota, Noriaki

AU - Okada, Morihito

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Purpose. The preoperative assessment of nodal status in lung cancer is complicated and problematic for physicians and surgeons. Although many patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) are candidates for surgical treatment, these patients represent a heterogeneous subgroup with unpredictable survival. We conducted this study to evaluate the surgical results of cN1 disease and to attempt to clarify the delicate issues surrounding its diagnosis and prognosis. Methods. The subjects of this study were 187 consecutive patients with cN1 adenocarcinoma or squamous cell carcinoma of the lung, who underwent complete resection without induction therapy. Results. Only 25% of the adenocarcinomas and 54% of the squamous cell carcinomas were correctly diagnosed as N1 disease preoperatively. Multiple logistic regression analyses revealed that adenocarcinoma (P = 0.0141) was a signifi cant predictor of pN2. Multivariate analyses revealed that nodal metastasis (P < 0.0001), large tumor size (P = 0.0079), and high serum carcinoembryonic antigen value (P = 0.0096) were signifi cantly poor prognostic factors in cN1 patients. Conclusions. It is diffi cult to diagnose nodal status in patients with cN1 disease, which requires various surgical procedures, including plasty, possibly with adjuvant therapy in a defi ned high-risk subgroup.

AB - Purpose. The preoperative assessment of nodal status in lung cancer is complicated and problematic for physicians and surgeons. Although many patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) are candidates for surgical treatment, these patients represent a heterogeneous subgroup with unpredictable survival. We conducted this study to evaluate the surgical results of cN1 disease and to attempt to clarify the delicate issues surrounding its diagnosis and prognosis. Methods. The subjects of this study were 187 consecutive patients with cN1 adenocarcinoma or squamous cell carcinoma of the lung, who underwent complete resection without induction therapy. Results. Only 25% of the adenocarcinomas and 54% of the squamous cell carcinomas were correctly diagnosed as N1 disease preoperatively. Multiple logistic regression analyses revealed that adenocarcinoma (P = 0.0141) was a signifi cant predictor of pN2. Multivariate analyses revealed that nodal metastasis (P < 0.0001), large tumor size (P = 0.0079), and high serum carcinoembryonic antigen value (P = 0.0096) were signifi cantly poor prognostic factors in cN1 patients. Conclusions. It is diffi cult to diagnose nodal status in patients with cN1 disease, which requires various surgical procedures, including plasty, possibly with adjuvant therapy in a defi ned high-risk subgroup.

UR - http://www.scopus.com/inward/record.url?scp=77955669809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955669809&partnerID=8YFLogxK

U2 - 10.1007/s00595-008-4072-4

DO - 10.1007/s00595-008-4072-4

M3 - Article

VL - 40

SP - 428

EP - 432

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 5

ER -